Lefebvre Eric
Chief Medical Officer at PLRX
- Sold, on record
- $5.1M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Jan 17, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PLRXPLIANT THERAPEUTICS, INC.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale PLRXPlan not statedOct 25 2022
Sold 5,000 shares at $25.05 ($125k)
Lefebvre Eric, Chief Medical Officer
Sold 3.6% of holdings ($3.5M position)133,437 shares left0.4x usual sizeFiling
- 2 Form 4 sale PLRXPlan not statedDec 20 +56 days
Sold 10,887 shares at $19.10 ($208k)
Lefebvre Eric, Chief Medical Officer
Sold 7% of holdings ($3M position)144,426 shares left1.2x usual sizeFiling
- 3 Form 4 sale PLRXUnusualJan 23 +34 days
Sold 67,500 shares at $34.48 ($2.3M)
Lefebvre Eric, Chief Medical Officer
Sold 46.7% of holdings ($5M position)76,926 shares left6.2x usual sizeFiling
- 4 Form 4 sale PLRXRoutineMar 30 +66 days
Sold 11,245 shares at $26.52 ($298k)
Lefebvre Eric, Chief Medical Officer
10b5-1 planSold 7.2% of holdings ($4.2M position)145,786 shares left1x usual sizeFiling
- 5 Form 4 sale PLRXRoutineJul 17 +109 days
Sold 22,321 shares at $18.01 ($402k)
Lefebvre Eric, Chief Medical Officer
10b5-1 planSold 11.8% of holdings ($3.4M position)167,215 shares left2.1x usual sizeFiling
- 6 Form 4 sale PLRXRoutineJan 17 +184 days
Sold 10,295 shares at $17.23 ($177k)
Lefebvre Eric, Chief Medical Officer
10b5-1 planSold 6.2% of holdings ($2.9M position)156,920 shares left0.9x usual sizeFiling
- 7 Form 4 sale PLRXRoutineJul 10 +175 days
Sold 12,319 shares at $11.56 ($142k)
Lefebvre Eric, Chief Medical Officer
10b5-1 planSold 5.5% of holdings ($2.6M position)213,052 shares left1.1x usual sizeFiling
- 8 Form 4 sale PLRXRoutineJan 17 +191 days
Sold 18,478 shares at $11.20 ($207k)
Lefebvre Eric, Chief Medical Officer
10b5-1 planSold 8.7% of holdings ($2.4M position)194,574 shares left1.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | PLRX | Chief Medical Officer | Form 4 sale | 18,478 | $207k | 8.7% | Routine | SEC |
| Jul 10, 2024 | PLRX | Chief Medical Officer | Form 4 sale | 12,319 | $142k | 5.5% | Routine | SEC |
| Jan 17, 2024 | PLRX | Chief Medical Officer | Form 4 sale | 10,295 | $177k | 6.2% | Routine | SEC |
| Jul 17, 2023 | PLRX | Chief Medical Officer | Form 4 sale | 22,321 | $402k | 11.8% | Routine | SEC |
| Mar 30, 2023 | PLRX | Chief Medical Officer | Form 4 sale | 11,245 | $298k | 7.2% | Routine | SEC |
| Jan 23, 2023 | PLRX | Chief Medical Officer | Form 4 sale | 67,500 | $2.3M | 46.7% | Unusual | SEC |
| Dec 20, 2022 | PLRX | Chief Medical Officer | Form 4 sale | 10,887 | $208k | 7.0% | Plan not stated | SEC |
| Oct 25, 2022 | PLRX | Chief Medical Officer | Form 4 sale | 5,000 | $125k | 3.6% | Plan not stated | SEC |
| Jul 11, 2022 | PLRX | Chief Medical Officer | Form 4 sale | 3,000 | $60k | 2.1% | Plan not stated | SEC |
| Jun 18, 2021 | PLRX | Chief Medical Officer | Form 4 sale | 12,500 | $361k | 8.4% | Plan not stated | SEC |
| Mar 18, 2021 | PLRX | Chief Medical Officer | Form 4 sale | 12,500 | $493k | 7.7% | Plan not stated | SEC |
| Dec 18, 2020 | PLRX | Chief Medical Officer | Form 4 sale | 12,500 | $332k | 7.2% | Plan not stated | SEC |